Different forms of the protein HNF4ɑ can pair up to influence diverse processes ranging from development to diabetes, study shows.
A collaboration between A*STAR and Duke-NUS Medical School has gotten closer to freeing some chronic hepatitis B patients from a life of medication
the liver’s ‘weak spot’ for hepatitis B virus replication, A*STAR scientists
are paving the way for new drug development efforts
Chronic hepatitis B virus enhances liver cancer susceptibility by blocking a key DNA repair enzyme
Structural analysis of the interaction between human leukocyte antigens and hepatitis B viruses reveals a path to better vaccine design
Gene therapy restores adaptive immunity in patients with chronic hepatitis B and directs T cells to tumor cells in patients with hepatitis B virus-related hepatocellular carcinoma